Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

ZYNE

Zynerba Pharmaceuticals (ZYNE)

Zynerba Pharmaceuticals Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:ZYNE
일자시간출처헤드라인심볼기업
2024/02/0909:22Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
2023/10/2005:48Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
2023/10/1213:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ZYNEZynerba Pharmaceuticals Inc
2023/10/1123:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZYNEZynerba Pharmaceuticals Inc
2023/10/1123:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZYNEZynerba Pharmaceuticals Inc
2023/10/1123:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZYNEZynerba Pharmaceuticals Inc
2023/10/1123:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZYNEZynerba Pharmaceuticals Inc
2023/10/1122:27Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ZYNEZynerba Pharmaceuticals Inc
2023/10/1122:27Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
2023/10/1122:24Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
2023/10/1122:22Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
2023/10/1122:22Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
2023/10/1122:22Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
2023/10/1122:22Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
2023/10/1122:21Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
2023/10/1122:20Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
2023/10/1122:19Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
2023/10/1122:19Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
2023/10/1121:56Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
2023/10/1121:31Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
2023/10/1121:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYNEZynerba Pharmaceuticals Inc
2023/10/1121:00PR Newswire (US)HARMONY BIOSCIENCES COMPLETES ACQUISITION OF ZYNERBA PHARMACEUTICALS AND EXPANDS PIPELINENASDAQ:ZYNEZynerba Pharmaceuticals Inc
2023/10/0506:29Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
2023/10/0505:05GlobeNewswire Inc.Important Information for Zynerba Pharmaceuticals Stockholders to Tender Shares for the Harmony Transaction: Process and InstructionsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
2023/09/2922:00GlobeNewswire Inc.Zynerba Pharmaceuticals Stockholders Reminded to Tender Shares Before 5:00 PM New York City Time, on Tuesday October 10, 2023NASDAQ:ZYNEZynerba Pharmaceuticals Inc
2023/09/2721:25Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
2023/09/2721:12Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
2023/09/2721:00PR Newswire (US)HARMONY BIOSCIENCES ANNOUNCES EXTENSION OF TENDER OFFER TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC.NASDAQ:ZYNEZynerba Pharmaceuticals Inc
2023/09/1521:00Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
2023/09/1505:59Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
 검색 관련기사 보기:NASDAQ:ZYNE